Abe M - Search Results

1

Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis.

Shimazaki C, Fuchida S, Suzuki K, Ishida T, Imai H, Sawamura M, Takamatsu H, Abe M, Miyamoto T, Hata H, Yamada M, Ando Y. Shimazaki C, et al. Among authors: abe m. Int J Hematol. 2016 Jan;103(1):79-85. doi: 10.1007/s12185-015-1901-2. Epub 2015 Nov 20. Int J Hematol. 2016. PMID: 26588925 Clinical Trial.

2

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma.

Murakami H, Fujii H, Inaba T, Shimazaki C, Okamoto S, Miwa A, Sawamura M, Abe M, Chou T, Asaoku H, Kitahara Y, Hayashi K, Kosaka M, Togawa A, Takatsuki K; Japan Myeloma Study Group. Murakami H, et al. Among authors: abe m. Eur J Haematol. 2004 Sep;73(3):169-73. doi: 10.1111/j.1600-0609.2004.00282.x. Eur J Haematol. 2004. PMID: 15287913 Clinical Trial.

3

Low-dose thalidomide plus low-dose dexamethasone therapy in patients with refractory multiple myeloma.

Murakami H, Handa H, Abe M, Iida S, Ishii A, Ishikawa T, Ishida T, Oota M, Ozaki S, Kosaka M, Sakai A, Sawamura M, Shimazaki C, Shimizu K, Takagi T, Hata H, Fukuhara T, Fujii H, Miyata A, Wakayama T, Takatsuki K. Murakami H, et al. Among authors: abe m. Eur J Haematol. 2007 Sep;79(3):234-9. doi: 10.1111/j.1600-0609.2007.00908.x. Epub 2007 Jul 26. Eur J Haematol. 2007. PMID: 17655699 Clinical Trial.

4

Therapy with bortezomib plus dexamethasone induces osteoblast activation in responsive patients with multiple myeloma.

Ozaki S, Tanaka O, Fujii S, Shigekiyo Y, Miki H, Choraku M, Kagawa K, Asano J, Takeuchi K, Kitazoe K, Hashimoto T, Abe M, Matsumoto T. Ozaki S, et al. Among authors: abe m. Int J Hematol. 2007 Aug;86(2):180-5. doi: 10.1532/IJH97.07030. Int J Hematol. 2007. PMID: 17875535 Clinical Trial.

5

Marked improvement of platelet transfusion refractoriness after bortezomib therapy in multiple myeloma.

Miki H, Ozaki S, Tanaka O, Lee E, Takimoto T, Watanabe H, Fujii S, Nakamura S, Kagawa K, Takeuchi K, Yata KI, Abe M, Kagami S, Matsumoto T. Miki H, et al. Among authors: abe m. Int J Hematol. 2009 Mar;89(2):223-226. doi: 10.1007/s12185-009-0255-z. Epub 2009 Feb 20. Int J Hematol. 2009. PMID: 19225725

6

Phase II and pharmacokinetic study of thalidomide in Japanese patients with relapsed/refractory multiple myeloma.

Murakami H, Shimizu K, Sawamura M, Suzuki K, Sugiura I, Kosugi H, Shimazaki C, Taniwaki M, Abe M, Takagi T. Murakami H, et al. Among authors: abe m. Int J Hematol. 2009 Jun;89(5):636-41. doi: 10.1007/s12185-009-0314-5. Epub 2009 Apr 28. Int J Hematol. 2009. PMID: 19399582 Clinical Trial.

7

A pharmacokinetic study evaluating the relationship between treatment efficacy and incidence of adverse events with thalidomide plasma concentrations in patients with refractory multiple myeloma.

Kodama T, Abe M, Iida S, Ozaki S, Sakai A, Sawamura M, Shimazaki C, Miyata A, Wakayama T, Murakami H. Kodama T, et al. Among authors: abe m. Clin Lymphoma Myeloma. 2009 Apr;9(2):154-9. doi: 10.3816/CLM.2009.n.037. Clin Lymphoma Myeloma. 2009. PMID: 19406727

8

Transient inflammatory reaction during lenalidomide plus reduced-dose dexamethasone therapy in two patients with relapsed multiple myeloma.

Ozaki S, Harada T, Fujii S, Nakamura S, Miki H, Nakano A, Kagawa K, Takeuchi K, Abe M, Matsumoto T. Ozaki S, et al. Among authors: abe m. Int J Hematol. 2011 Feb;93(2):257-259. doi: 10.1007/s12185-011-0775-1. Epub 2011 Feb 1. Int J Hematol. 2011. PMID: 21279817 No abstract available.

9

Delayed treatment with vitamin C and N-acetyl-L-cysteine protects Schwann cells without compromising the anti-myeloma activity of bortezomib.

Nakano A, Abe M, Oda A, Amou H, Hiasa M, Nakamura S, Miki H, Harada T, Fujii S, Kagawa K, Takeuchi K, Watanabe T, Ozaki S, Matsumoto T. Nakano A, et al. Among authors: abe m. Int J Hematol. 2011 Jun;93(6):727-735. doi: 10.1007/s12185-011-0850-7. Epub 2011 Apr 28. Int J Hematol. 2011. PMID: 21526377

10

TRAIL produced from multiple myeloma cells is associated with osteolytic markers.

Kawano Y, Ueno S, Abe M, Kikukawa Y, Yuki H, Iyama K, Okuno Y, Mitsuya H, Hata H. Kawano Y, et al. Among authors: abe m. Oncol Rep. 2012 Jan;27(1):39-44. doi: 10.3892/or.2011.1491. Epub 2011 Oct 6. Oncol Rep. 2012. PMID: 21993926

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,229 results

Search Page

Filters